Stock search

Ticker or company name

Compare stocks

Market: US

  • ILMNIllumina, Inc.
  • WSTWest Pharmaceutical Services
  • MTDMettler Toledo

Add stock

Ticker or company

Summary

ILMN
Illumina, Inc.
$198,00Down −4,35%
Year: Up +73%
75/100Ratio would consider buying
Open stock page
WST
West Pharmaceutical Services
$417,80Up +0,33%
Year: Up +56%
83/100Best scoreRatio would consider buying
Open stock page
MTD
Mettler Toledo
$1 727,26Down −0,67%
Year: Up +23%
63/100Ratio would watch
Open stock page

Verdict

WST has the best score (83). WST grows revenue the fastest. MTD is the cheapest by forward P/E. ILMN has the lowest debt load. MTD has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckILMN5 ✓ 2 — 1 ✕WST7 ✓ 1 — 1 ✕MTD3 ✓ 4 — 1 ✕
P/E vs its historyn/a33,645,536,5
P/E vs industry33,645,536,5
Forward P/E39,140,535,9
Revenue growth, YoY+5,8%+12,6%+6,5%
EPS growth, YoY+30,3%+32,0%+15,0%
Net margin19,7%18,8%22,2%
Net debt / EBITDA−1,1−0,3n/a—
Free cash flow$1,06 bn$453 m$871 m
Share count over a year0,0%−2,5%−2,7%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterILMNTTMWSTTTMMTDTTMIndustry medianTTM
P/E TTM ↓Best: 33,6Worst: 45,536,537,9
Forward P/E ↓39,1Worst: 40,5Best: 35,929,5
PEG ↓Worst: 3,42,6Best: 2,53,7
P/S TTM ↓Best: 6,6Worst: 8,68,16,6
EV/EBITDA ↓Best: 26,3Worst: 30,029,929,9
P/FCF ↓Best: 28,5Worst: 64,239,238,7

Price, %

  • ILMNn/a
  • WSTn/a
  • MTDn/a

Returns

Best WorstNo mark — in between

PeriodILMNWSTMTD
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

ILMNWSTMTD
Share of “buy”54%Best: 95%Worst: 47%
Beat the forecast4 of 44 of 44 of 4
Average “surprise”+5,8%Best: +17,2%Worst: +3,2%
Insiders over 12 monthssales $721 msales $6,57 msales $20,3 m

Details are on each stock page.